Business Description
Creative Medical Technology Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US22529Y4089
Total Employee Number:
4Description
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.95 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -7.29 | |||||
Beneish M-Score | -4.16 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -66.7 | |||||
3-Year EBITDA Growth Rate | 35.2 | |||||
3-Year EPS without NRI Growth Rate | 35.2 | |||||
3-Year FCF Growth Rate | 29.9 | |||||
3-Year Book Growth Rate | -43.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 30.33 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 25.87 | |||||
9-Day RSI | 28.22 | |||||
14-Day RSI | 29.87 | |||||
3-1 Month Momentum % | -13.04 | |||||
6-1 Month Momentum % | -4.76 | |||||
12-1 Month Momentum % | -26.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 19.67 | |||||
Quick Ratio | 19.67 | |||||
Cash Ratio | 18.99 | |||||
Days Inventory | 456.25 | |||||
Days Payable | 98258 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -38 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 66.67 | |||||
Operating Margin % | -198066.67 | |||||
Net Margin % | -192066.67 | |||||
EBITDA Margin % | -194000 | |||||
FCF Margin % | -190466.67 | |||||
OCF Margin % | -186300 | |||||
ROE % | -84.47 | |||||
ROA % | -81.03 | |||||
ROIC % | -1344.95 | |||||
3-Year ROIIC % | -14646.43 | |||||
ROCE % | -87.03 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 810.2 | |||||
PB Ratio | 0.49 | |||||
Price-to-Tangible-Book | 0.52 | |||||
EV-to-EBIT | 0.1 | |||||
EV-to-EBITDA | 0.1 | |||||
EV-to-Revenue | -189.67 | |||||
EV-to-Forward-Revenue | 553.99 | |||||
EV-to-FCF | 0.1 | |||||
Price-to-GF-Value | 2.53 | |||||
| Price-to-Net-Current-Asset-Value | 0.52 | |||||
| Price-to-Net-Cash | 0.54 | |||||
Earnings Yield (Greenblatt) % | 1000 | |||||
FCF Yield % | -108.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CELZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
Creative Medical Technology Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.003 | ||
| EPS (TTM) ($) | -2.14 | ||
| Beta | 1.14 | ||
| 3-Year Sharpe Ratio | -0.19 | ||
| 3-Year Sortino Ratio | -0.26 | ||
| Volatility % | 54.73 | ||
| 14-Day RSI | 29.87 | ||
| 14-Day ATR ($) | 0.202382 | ||
| 20-Day SMA ($) | 0.972345 | ||
| 12-1 Month Momentum % | -26.47 | ||
| 52-Week Range ($) | 0.7811 - 6.25 | ||
| Shares Outstanding (Mil) | 6.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Creative Medical Technology Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Creative Medical Technology Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-06 | In 103 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 12 days | ||
| First quarter earnings results for 2026 | 2026-05-08 | 2.29 (+1.78%) | ||
| Annual report for 2025 | 2026-03-20 | 1.88 (-0.53%) | ||
| Third quarter earnings results for 2025 | 2025-11-07 | 2.97 (+4.95%) | ||
| Second quarter earnings results for 2025 | 2025-08-08 | 3.73 (+5.97%) | ||
| First quarter earnings results for 2025 | 2025-05-09 | 2.09 (+8.29%) | ||
| Annual report for 2024 | 2025-03-14 | 3.00 (-15.49%) | ||
| Third quarter earnings results for 2024 | 2024-11-08 | 3.16 (-0.94%) | ||
| Second quarter earnings results for 2024 | 2024-08-09 | 3.02 (+1.00%) |
Show
Entries
Creative Medical Technology Holdings Inc Frequently Asked Questions
What is Creative Medical Technology Holdings Inc(CELZ)'s stock price today?
The current price of CELZ is $0.81. The 52 week high of CELZ is $6.25 and 52 week low is $0.78.
When is next earnings date of Creative Medical Technology Holdings Inc(CELZ)?
The next earnings date of Creative Medical Technology Holdings Inc(CELZ) is 2026-08-07 Est..
Does Creative Medical Technology Holdings Inc(CELZ) pay dividends? If so, how much?
Creative Medical Technology Holdings Inc(CELZ) does not pay dividend.
Guru Commentaries on NAS:CELZ
No articles.
Press Release
Articles on Creative Medical Technology Holdings Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers